4//SEC Filing
Gayron Kenneth L 4
Accession 0001372514-23-000143
CIK 0001372514other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:44 PM ET
Size
5.4 KB
Accession
0001372514-23-000143
Insider Transaction Report
Form 4
Gayron Kenneth L
Director
Transactions
- Award
Stock Option (right to buy)
2023-09-29+5,000→ 5,000 totalExercise: $0.57Exp: 2033-09-29→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024.
Documents
Issuer
KIORA PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001669103
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:44 PM ET
- Size
- 5.4 KB